Generation Bio
GBIO
GBIO
75 hedge funds and large institutions have $217M invested in Generation Bio in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 25 increasing their positions, 26 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
5% less funds holding
Funds holding: 79 → 75 (-4)
31% less capital invested
Capital invested by funds: $315M → $217M (-$98.3M)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Holders
75
Holding in Top 10
1
Calls
$24K
Puts
$17K
Top Buyers
| 1 | +$1.93M | |
| 2 | +$646K | |
| 3 | +$456K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$443K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$301K |
Top Sellers
| 1 | -$2.81M | |
| 2 | -$719K | |
| 3 | -$694K | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$315K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$174K |